Related Experiment Videos
RESPIRE Score: Derivation and Validation of a New Risk Score for Prediction of Community-acquired Pneumonia Caused by
Lorenzo Pelagatti1,2, Martina De Marco1, Emma Bosco1
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Background:
Community-acquired pneumonia (CAP) remains a leading cause of infectious mortality worldwide. The increasing prevalence of multidrug-resistant (MDR) pathogens challenges the established empirical antibiotic therapy schemes. This study aimed to derive and validate a clinical score (RESPIRE) to identify CAP-MDR patients.
Methods:
We conducted an observational study in a setting of medium-high multidrug-resistant (MDR) endemicity. The primary outcome was the derivation of a clinical score predicting MDR-CAP. A retrospective derivation cohort (January 2022-December 2023) including adult patients hospitalized with microbiologically confirmed CAP by culture on respiratory samples was used for score derivation. A prospective cohort (January 2024-December 2025) including adult patients with the same clinical features was used for score validation.
Results:
The derivation cohort included 275 patients (mean age 68.3 years), with an MDR prevalence of 30.1% (n = 83). The RESPIRE score assigns 1.5 points for recent hospitalization and prior antibiotic use, and 1 point each for enteral feeding, poor functional status, and residence in long-term care facilities (maximum 6 points). A cutoff ≥ 2 showed optimal performance in predicting CAP-MDR (AUROC 0.85; 95% CI 0.80-0.91), outperforming other scores except DRIP. Validation in 141 patients (39% MDR) confirmed an AUROC of 0.88 (95% CI 0.74-0.89) showing better performance compared to other diagnostic models.
Conclusions:
The RESPIRE score outperformed HCAP criteria and other clinical scores in predicting CAP-MDR. Its implementation in protocols could support antimicrobial stewardship for empiric treatment of cases of CAP presenting at the Emergency Department. A multicenter validation is warranted to confirm the performance of the RESPIRE score.
Trial Registration Number:
NCT07425561.
Related Concept Videos
01:20Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
01:23Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...